HomeSANN • SWX
add
Santhera Pharmaceuticals Holding AG
Previous close
CHF 9.37
Day range
CHF 9.20 - CHF 9.46
Year range
CHF 6.05 - CHF 14.62
Market cap
117.54M CHF
Avg Volume
24.53K
P/E ratio
1.92
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(CHF) | Jun 2023info | Y/Y change |
---|---|---|
Revenue | 1.97M | -36.98% |
Operating expense | 11.16M | -19.76% |
Net income | -11.67M | 21.49% |
Net profit margin | -592.43 | -24.57% |
Earnings per share | — | — |
EBITDA | -9.24M | 14.52% |
Effective tax rate | 0.36% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Jun 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.67M | -86.82% |
Total assets | 63.08M | -20.94% |
Total liabilities | 105.84M | 13.04% |
Total equity | -42.76M | — |
Shares outstanding | 9.20M | — |
Price to book | -2.02 | — |
Return on assets | -40.24% | — |
Return on capital | 2,022.41% | — |
Cash Flow
Net change in cash
(CHF) | Jun 2023info | Y/Y change |
---|---|---|
Net income | -11.67M | 21.49% |
Cash from operations | -7.68M | -28.44% |
Cash from investing | 2.84M | — |
Cash from financing | 4.99M | 186.10% |
Net change in cash | 160.50K | 103.77% |
Free cash flow | -6.99M | 15.81% |
About
Founded
2004
Website
Employees
46